Israel's DreaMed gets FDA ok for diabetes management software
June 18, 2018 at 07:30 AM EDT
TEL AVIV, June 18 (Reuters) - Israel's DreaMed Diabetes said on Monday the U.S. Food and Drug Administration has approved for marketing its Advisor Pro software to help manage diabetes treatment.
